@VisweshPharmD @TheIDApprentice @theIDPharmD @InYourFAECIUM @MBrigmon @julie_justo @Cortes_Penfield @MK_IDpharm @IDstewardship All great points! What I was trying to say is that, at least in vitro, it seems that eravacycline is potentially more potent agai
Pleased to have published another excellent review by George Zhanel and his group - on eravacycline https://t.co/tZj78QiYfO
RT @DineshMFernando: https://t.co/0U1LEdtwCO #eravacycline is 2-8 fold more potent than tetracycline against #MDR bacteria, phase3 complete…
https://t.co/0U1LEdtwCO #eravacycline is 2-8 fold more potent than tetracycline against #MDR bacteria, phase3 complete. @KhemKishan
Our new review article on Eravacycline. Thank You Prof Zhanel and Prof Frank Schweizer https://t.co/WgtVJJreEE #springerlink
Oral Bioavailability of Eravacycline is ~ 28%, so clearly an issue with intestinal permeability/metabolism. https://t.co/YH5K3HbLYp
$TTPH new review on eravacycline..... https://t.co/yafiknFLpX
Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent. https://t.co/zGjjnJOi9N